Judge Gives Go-Ahead To Prilosec Patent Suit
A federal judge on Friday denied generic drug maker Impax Laboratories Inc.'s motion to dismiss a longstanding patent dispute with AstraZeneca AB after patents for its gastric acid-inhibiting drug, Prilosec, expired....To view the full article, register now.
Already a subscriber? Click here to view full article